Stay updated on Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and NIH operations was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-03T23:48:32.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a Show glossary option, added Last Update Submitted that Met QC Criteria, added No FEAR Act Data, and updated Revision: v3.4.0; removed Last Update Submitted that met QC Criteria, removed No FEAR Act data, and removed Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-27T23:57:27.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and v3.3.3 was removed; there are no changes to the study details, eligibility criteria, locations, or primary/secondary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:46:12.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Locations section now consolidates and lists participating sites by state (Arizona, California, Florida, Iowa, Massachusetts, Minnesota, Mississippi, New York, North Carolina, Ohio, Oregon, Rhode Island, Tennessee, Texas, Virginia). The HHS Vulnerability Disclosure link was removed and the page revision is updated to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T08:14:57.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:49:45.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and introduced a revision tag labeled v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:39:29.000Z thumbnail image

Stay in the know with updates to Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page.